Term ended Nov 8, 2026 · Medium confidence
20-year base term ended Nov 8, 2026
Why Medium: A parent in the chain could not be resolved.
Filed May 5, 2008 as application 12/114,935 · Granted Mar 31, 2015
Base term plus 1494 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
Term ended Nov 8, 2026
2006
2026
Clock starts
Nov 8, 2006
Nov 8, 2006
Term ended
Nov 8, 2026
Nov 8, 2026
Granted
Mar 31, 2015
Mar 31, 2015
base term
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,494
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,659,268, US 7,741,321, US 7,956,052, US 8,324,207.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
29
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1494 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 8, 2006, when application PCT/US2006/043289, the earliest non-provisional in its chain, was filed (this one was filed May 5, 2008); a parent in its chain could not be resolved (the next row) | Nov 8, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +1494 days, USPTO patent term adjustment record | Dec 11, 2030 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,659,268, US 7,741,321, US 7,956,052, US 8,324,207) | capped to Nov 8, 2026 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Nov 8, 2026 | Medium confidence |
This family
| US 8,759,335 | Term ended May 2025 | May 2025 |
| US 7,977,322 | Term ended May 2025 | May 2025 |
| Application PCT/US2006/043289 | PCT application no patent term | no patent term |
| US 7,741,321 | In force Mar 2028 | Mar 2028 |
| US 7,659,268 | In force May 2027 | May 2027 |
| US 8,993,600 | this patent Nov 2026 | Nov 2026 |
| US 7,754,739 | In force Jun 2028 | Jun 2028 |
| US 7,956,052 | Term ended Nov 2026 | Nov 2026 |
8 of 29 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 20, 2013 Reel 31252, frame 325 | Hadida Ruah, Sara; Hamilton, Matthew; Miller, Mark; Grootenhuis, Peter; Bear, Brian; McCartney, Jason; Zhou, Jinglan; Vangoor, Fredrick | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Jul 10, 2014 Reel 33292, frame 311 | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Macquarie US Trading LLC | Security Interest |
| Feb 2, 2016 Reel 37681, frame 375 | Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated | Assignee Change of Address |
| Feb 3, 2016 Reel 37685, frame 878 | Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated | Assignee Change of Address |
| Oct 14, 2016 Reel 40357, frame 1 | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 1494 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 7,659,268, US 7,741,321, US 7,956,052, US 8,324,207.
Citations
154
later US patents cite this one
That is top 5% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.